Kimberly-Clark pursues spin-off of health care business
(Reuters) - Kimberly-Clark Corp, the maker of Kleenex tissues, said its board authorized a potential spin-off of its health care business, sending its shares up 6 percent in extended trading.
The company said the move would enable it to focus on its consumer and K-C professional brands.
Kimberly-Clark said Robert Abernathy, currently group president - Europe, global nonwovens and continuous improvement and sustainability, will become chief executive of the new health care company if its spun off.
The company said it expects to make a final recommendation regarding in the next several months. If the spin-off is approved, the transaction would be completed by the end of the third quarter of 2014.
Morgan Stanley has been retained by the company in pursuit of the spin-off.
Kimberly-Clark's health care business sells surgical and infection prevention products for the operating room, as well as medical devices. It posted net sales of $1.6 billion in 2012.
The company's shares were trading at $116.60 after markets closed. They had closed at $109.71 on the New York Stock Exchange on Thursday.
(Reporting By Maria Ajit Thomas in Bangalore; Editing by Joyjeet Das)
- Thousands of Gaza civilians flee after Israeli warning |
- Russia threatens Ukraine after shell crosses border
- Three dead, two wounded in Pasadena, California shootings
- Teen survivor of Texas shootings says slain family members 'in much better place'
- Heavy fighting breaks out near Libya's Tripoli airport, seven dead
Robert Blendon of the Harvard School of Public Health says the Affordable Care Act's unpopularity in 12 key states will keep it a central issue in the 2014 elections. Video